why choose us

First received: October 04, 2024

Clinical Trial: Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pelvic Cancer

Study Type: INTERVENTIONAL


Official Title: Effect of Dexmedetomidine/Lidocaine, Ketamine/Lidocaine and Lidocaine Alone on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries: Randomised Prospective Study

Brief Summary: The investigators hypothesize that effect of addition of dexmedetomidine or ketamine by IV infusion to lidocaine infusion may be more beneficial than lidocaine infusion alone on proinflammatory cytokines (IL-1, IL-6 and TNF?), and postoperative pain relief and decreased opioid consumption, reduced Length of stay.

Read more